Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed plus cisplatin as adjuvant chemotherapy for post-operative lung adenocarcinoma (Phase II)
KCT0002816Phase 2Active, not recruiting
- Sponsor
- Shinpoong Pharma
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, cisplatin in Non-small cell lung cancer adenocarcinoma (NSCLC), sponsored by Shinpoong Pharma. Started Aug 2015; status: active, not recruiting.
02
Drugs
pemetrexedcisplatin
03
Conditions
Non-small cell lung cancer adenocarcinoma (NSCLC)
Beyond the preview
Go deeper on KCT0002816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002816.